The idea that any of these astrocytic functions are disrupted in AD or FAD mice was initially based on GFAP staining, as when activated the levels of GFAP (intermediate filaments prominent in processes) are higher in astrocytes. The gene discussed is GFAP; the disease is Alzheimer disease.